Kinaxis Strengthens Ono Pharmaceutical's Global Supply Chain Operations

Partnership set to enhance efficiency and support global expansion of innovative medicines.

Kinaxis® Inc., a global leader in supply chain orchestration, has announced its collaboration with Ono Pharmaceutical Co., Ltd. (ONO) to enhance transparency and operational efficiency across ONO’s global supply chain. Headquartered in Osaka, Japan, ONO is an R&D-driven pharmaceutical company known for developing innovative medicines in oncology, immunology, and neurology.

With the adoption of Kinaxis Maestro™, an AI-powered supply chain platform, ONO aims to optimize its global operations as it prepares to expand direct sales in the U.S. and Europe. The platform will streamline ONO's supply chain, ensuring the efficient delivery of its life-saving drugs worldwide.

Akira Takada, corporate executive officer at ONO, emphasized the importance of this partnership in supporting the company’s mission to combat disease and pain while contributing to a sustainable society. "Kinaxis will be crucial in ensuring the stable delivery of our medicines across a broad range of therapeutic areas," he said.

Toshiya Kaneko, president at Kinaxis Japan, highlighted the platform's ability to bolster ONO’s resilience in the face of global challenges, enabling them to plan for any scenario and maintain their commitment to patients.

With ONO joining its growing list of life sciences clients, Kinaxis continues to solidify its presence in the pharmaceutical industry, serving top companies like Merck, Novartis, and Siemens Healthineers.